| 0 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
2 |
0.0020 |
| 1 |
Progestin Antagonist [EPC] |
4 |
0.0008 |
| 2 |
Blood Viscosity Reducer [EPC] |
2 |
0.0005 |
| 3 |
Vitamin K [EPC] |
2 |
0.0002 |
| 4 |
Potassium-sparing Diuretic [EPC] |
2 |
0.0001 |
| 5 |
Somatostatin Analog [EPC] |
1 |
0.0001 |
| 6 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
1 |
0.0001 |
| 7 |
Cannabinoid [EPC] |
1 |
0.0001 |
| 8 |
General Anesthetic [EPC] |
5 |
0.0001 |
| 9 |
Barbiturate [EPC] |
1 |
0.0001 |
| 10 |
Androgen [EPC] |
2 |
0.0001 |
| 11 |
Provitamin D2 Compound [EPC] |
2 |
0.0001 |
| 12 |
Recombinant Human Growth Hormone [EPC] |
1 |
0.0000 |
| 13 |
Aldosterone Antagonist [EPC] |
7 |
0.0000 |
| 14 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
2 |
0.0000 |
| 15 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0000 |
| 16 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
4 |
0.0000 |
| 17 |
Ester Local Anesthetic [EPC] |
2 |
0.0000 |
| 18 |
PCSK9 Inhibitor [EPC] |
1 |
0.0000 |
| 19 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 20 |
Central alpha-2 Adrenergic Agonist [EPC] |
2 |
0.0000 |
| 21 |
Dihydropyridine Calcium Channel Blocker [EPC] |
12 |
0.0000 |
| 22 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
4 |
0.0000 |
| 23 |
Amide Local Anesthetic [EPC] |
3 |
0.0000 |
| 24 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
1 |
0.0000 |
| 25 |
Antiarrhythmic [EPC] |
3 |
0.0000 |
| 26 |
Non-Standardized Chemical Allergen [EPC] |
2 |
0.0000 |
| 27 |
Histamine-2 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 28 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Thiazide Diuretic [EPC] |
4 |
0.0000 |
| 30 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
2 |
0.0000 |
| 31 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 32 |
Osmotic Laxative [EPC] |
5 |
0.0000 |
| 33 |
Vitamin C [EPC] |
7 |
0.0000 |
| 34 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 35 |
Angiotensin 2 Receptor Blocker [EPC] |
5 |
0.0000 |
| 36 |
Expectorant [EPC] |
3 |
0.0000 |
| 37 |
alpha-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 38 |
Vitamin D [EPC] |
4 |
0.0000 |
| 39 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
Vitamin B12 [EPC] |
4 |
0.0000 |
| 41 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 42 |
Nitrate Vasodilator [EPC] |
1 |
0.0000 |
| 43 |
Acetylcholine Release Inhibitor [EPC] |
1 |
0.0000 |
| 44 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 45 |
RANK Ligand Inhibitor [EPC] |
2 |
0.0000 |
| 46 |
Interleukin-12 Antagonist [EPC] |
1 |
0.0000 |
| 47 |
Interleukin-23 Antagonist [EPC] |
1 |
0.0000 |
| 48 |
Insulin Analog [EPC] |
4 |
0.0000 |
| 49 |
Aromatase Inhibitor [EPC] |
1 |
0.0000 |
| 50 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 51 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 52 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 53 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 55 |
GLP-1 Receptor Agonist [EPC] |
3 |
0.0000 |
| 56 |
Calcium [EPC] |
1 |
0.0000 |
| 57 |
Loop Diuretic [EPC] |
3 |
0.0000 |
| 58 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 59 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
8 |
0.0000 |
| 60 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 61 |
Benzodiazepine [EPC] |
4 |
0.0000 |
| 62 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 63 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 64 |
Estrogen [EPC] |
1 |
0.0000 |
| 65 |
Platelet Aggregation Inhibitor [EPC] |
3 |
0.0000 |
| 66 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 67 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 68 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 69 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 70 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 71 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 72 |
Corticosteroid [EPC] |
3 |
0.0000 |
| 73 |
Tumor Necrosis Factor Blocker [EPC] |
2 |
0.0000 |
| 74 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |